To investigate whether the effects could be replicated in breast cancer cells, we used short interfering RNA (siRNA) to downregulate endogenous BRCA1 in ER-positive MCF7 and T47D breast cancer cell lines which have relatively high abundance of BRCA1 (Supplementary Figure 1). The gene discussed is BRCA1; the disease is breast cancer.